Right subaxillary small incision on low-age and low-weight infants with congenital heart disease

Xiaoyong Jing1, Lun Li1, Yongtao Wu1

  • 1Pediatric Heart Center, Beijing Anzhen Hospital, Beijing, China.

PubMed

Insights

Right subaxillary small incision (RSSI) surgery offers a safe and effective minimally invasive option for treating congenital heart disease (CHD) in low-age, low-weight infants. This approach results in shorter hospital stays and reduced trauma compared to traditional median sternotomy.

Area of Science:

  • Pediatric Cardiac Surgery
  • Minimally Invasive Cardiac Surgery
  • Congenital Heart Disease Treatment

Background:

  • The right subaxillary small incision (RSSI) is an evolving minimally invasive technique for congenital heart disease (CHD).
  • Its application in low-age and low-weight infants presents unique surgical challenges.

Purpose of the Study:

  • To evaluate the safety and efficacy of RSSI surgery for treating CHD in infants with low age and weight.
  • To compare RSSI with traditional median sternotomy (MS) in this patient cohort.

Main Methods:

  • Retrospective study of 783 infants (≤6 months, ≤5kg) with septal defects from March 2010 to April 2023.
  • Propensity score matching (PSM) created comparable RSSI (282 cases) and MS (282 cases) groups.
  • Comparison of preoperative, perioperative, postoperative, and long-term outcomes.

Main Results:

  • No significant differences in residual defects or key respiratory parameters post-PSM.
  • RSSI group showed significantly shorter mechanical ventilation, ICU, and hospitalization times (P<0.001).
  • Perioperative complications were similar; lower rates of thoracic deformity in the RSSI group long-term.

Conclusions:

  • RSSI surgery is a favorable therapeutic option for selected low-age, low-weight infants with CHD.
  • It achieves comparable outcomes to MS with reduced trauma and shorter recovery periods.
  • The RSSI technique warrants further promotion and application in pediatric cardiac surgery.
Abstract